![PRD_000822 PRD_000822](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000822.svg) | PRD_000822 | Name: | ALKIDNMD peptide | Formula: | C38 H65 N10 O13 S | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000823 PRD_000823](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000823.svg) | PRD_000823 | Name: | N-propanoyl-D-alanyl-(4R)-4-[(7-bromoisoquinolin-1-yl)oxy]-N-{(1R,2R)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}-L-prolinamide | Formula: | C29 H34 Br N5 O7 S | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000824 PRD_000824](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000824.svg) | PRD_000824 | Name: | SLKIDNED peptide | Formula: | C38 H63 N10 O16 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000825 PRD_000825](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000825.svg) | PRD_000825 | Name: | ATKIDNLD peptide | Formula: | C37 H63 N10 O14 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000826 PRD_000826](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000826.svg) | PRD_000826 | Name: | SRKIDNLD peptide | Formula: | C39 H69 N13 O14 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000827 PRD_000827](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000827.svg) | PRD_000827 | Name: | SHKIDNLD peptide | Formula: | C39 H64 N12 O14 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000828 PRD_000828](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000828.svg) | PRD_000828 | Name: | Trichovirin I-4A | Formula: | C67 H115 N15 O16 | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
![PRD_000829 PRD_000829](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000829.svg) | PRD_000829 | Name: | OS1 peptide | Formula: | C51 H87 N17 O16 S3 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000833 PRD_000833](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000833.svg) | PRD_000833 | Name: | 5-methyltetrahydrofolate pentaglutamate | Formula: | C40 H53 N11 O18 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000842 PRD_000842](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000842.svg) | PRD_000842 | Name: | PTA-SFTI INHIBITOR | Formula: | C66 H106 N20 O18 S2 | Description: | Bowman-Birk Inhibitor | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000843 PRD_000843](https://data.pdbj.org/pdbjplus/data/cc/svg/MCX.svg) | PRD_000843 | Name: | (1R,2S,5S)-N-[(2S,3R)-4-amino-1-cyclobutyl-3-hydroxy-4-oxobutan-2-yl]-6,6-dimethyl-3-{3-methyl-N-[(1-methylcyclohexyl)c
arbamoyl]-L-valyl}-3-azabicyclo[3.1.0]hexane-2-carboxamide | Formula: | C30 H51 N5 O5 | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
![PRD_000845 PRD_000845](https://data.pdbj.org/pdbjplus/data/cc/svg/L4T.svg) | PRD_000845 | Name: | N-[(cyclopentyloxy)carbonyl]-3-methyl-L-valyl-(4R)-4-[(8-bromo-7-methoxy-2-{2-[(2-methylpropanoyl)amino]-1,3-thiazol-4-yl}quinolin-4-yl)oxy]-N-[(1R,2S)-1-carboxy-2-ethenylcyclopropyl]-L-prolinamide | Formula: | C40 H49 Br N6 O9 S | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000846 PRD_000846](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000846.svg) | PRD_000846 | Name: | TRYPSIN INHIBITOR 1 | Formula: | C66 H106 N20 O18 S2 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000849 PRD_000849](https://data.pdbj.org/pdbjplus/data/cc/svg/L5T.svg) | PRD_000849 | Name: | N-[(cyclopentyloxy)carbonyl]-3-methyl-L-valyl-(4R)-N-[(1R,2S)-1-carboxy-2-ethenylcyclopropyl]-4-[(7-methoxy-2-{2-[(2-methylpropanoyl)amino]-1,3-thiazol-4-yl}quinolin-4-yl)oxy]-L-prolinamide | Formula: | C40 H50 N6 O9 S | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000854 PRD_000854](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000854.svg) | PRD_000854 | Name: | DB6 peptide | Formula: | C57 H77 N13 O11 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000855 PRD_000855](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000855.svg) | PRD_000855 | Name: | DB5 peptide | Formula: | C49 H74 N15 O10 S | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000857 PRD_000857](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000857.svg) | PRD_000857 | Name: | SAH-p53-8 stapled-peptide | Formula: | C96 H151 N26 O25 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000870 PRD_000870](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000870.svg) | PRD_000870 | Name: | bisubstrate inhibitor | Formula: | C23 H30 N6 O18 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000877 PRD_000877](https://data.pdbj.org/pdbjplus/data/cc/svg/BJA.svg) | PRD_000877 | Name: | (2S)-1-[(2R)-2-(benzylsulfonylamino)-5-guanidino-pentanoyl]-N-[(4-carbamimidoylphenyl)methyl]pyrrolidine-2-carboxamide | Formula: | C26 H36 N8 O4 S | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
![PRD_000887 PRD_000887](https://data.pdbj.org/pdbjplus/data/cc/svg/S33.svg) | PRD_000887 | Name: | (2S)-N-[[2-(aminomethyl)-5-chloranyl-phenyl]methyl]-1-[(2S)-2-[(3-chloranyl-4-methoxy-phenyl)sulfonylamino]-4-[(4-cyanophenyl)methylamino]-4-oxidanylidene-butanoyl]pyrrolidine-2-carboxamide | Formula: | C32 H34 Cl2 N6 O6 S | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
![PRD_000892 PRD_000892](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000892.svg) | PRD_000892 | Name: | METHYL (2R)-1-[(6S,9S,12S,13S,17S,20S,23R)-9-(3-AMINO-3-OXOPROPYL)-12,23-DIBENZYL-13-HYDROXY-2,2,8,20,22-PENTAMETHYL-17-(2-METHYLPROPYL)-4,7,10,15,18,21,24-HEPTAOXO-6-(PROPAN-2-YL)-3-OXA-5,8,11,16,19,22-HEXAAZATETRACOSAN-24-YL]PYRROLIDINE-2-CARBOXYLATE | Formula: | C52 H78 N8 O12 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000554 PRD_000554](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_000554.svg) | PRD_000554 | Name: | Cyclotheonamide A | Formula: | C36 H46 N9 O8 | Definition date: | 2012-02-03 | Last modified: | 2023-11-03 |
|